StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$333.25+1.09 (+0.33%)

Close on Nov 18, 2026Market cap $15.91BP/E –Yield –

Charles River Laboratories International market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Charles River Laboratories International's market cap was $16.41B on Nov 11, 2026, against $8.77B a year earlier. Over the last 5 years it ranged from $6.07B to $19.01B, with a median of $10.60B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.41B+67.1%
2025Dec 31, 2025$9.82B+4.0%
2024Dec 31, 2024$9.44B-22.2%
2023Dec 29, 2023$12.13B+9.4%
2022Dec 30, 2022$11.09B-41.7%
2021Dec 31, 2021$19.01B+53.0%
2020Dec 31, 2020$12.43B+66.6%
2019Dec 31, 2019$7.46B+37.1%
2018Dec 31, 2018$5.44B+5.1%
2017Dec 29, 2017$5.18B+43.7%
2016Dec 30, 2016$3.61B-3.8%
2015Dec 31, 2015$3.75B+25.9%
2014Dec 31, 2014$2.98B-99.9%
2013Dec 31, 2013$2.56T+140844.7%
2012Dec 31, 2012$1.82B+33.6%
2011Dec 30, 2011$1.36B-33.7%
2010Dec 31, 2010$2.05B–

More Charles River Laboratories International figures

See a number that looks wrong?